Myeloid-derived growth factor alleviates non-alcoholic fatty liver disease alleviates in a manner involving IKKβ/NF-κB signaling

MLA

Yan Ding, et al. “Myeloid-Derived Growth Factor Alleviates Non-Alcoholic Fatty Liver Disease Alleviates in a Manner Involving IKKβ/NF-ΚB Signaling.” Cell Death and Disease, vol. 14, no. 6, June 2023, pp. 1–17. EBSCOhost, https://doi.org/10.1038/s41419-023-05904-y.

APA

Yan Ding, Xiaoli Xu, Biying Meng, Li Wang, Biao Zhu, Bei Guo, Jiajia Zhang, Lin Xiang, Jing Dong, Min Liu, & Guangda Xiang. (2023). Myeloid-derived growth factor alleviates non-alcoholic fatty liver disease alleviates in a manner involving IKKβ/NF-κB signaling. Cell Death and Disease, 14(6), 1–17. https://doi.org/10.1038/s41419-023-05904-y

Chicago

Yan Ding, Xiaoli Xu, Biying Meng, Li Wang, Biao Zhu, Bei Guo, Jiajia Zhang, et al. 2023. “Myeloid-Derived Growth Factor Alleviates Non-Alcoholic Fatty Liver Disease Alleviates in a Manner Involving IKKβ/NF-ΚB Signaling.” Cell Death and Disease 14 (6): 1–17. doi:10.1038/s41419-023-05904-y.